OptiNose Market Cap

OptiNose has a market cap or net worth of $116.03 million as of April 22, 2024. Its market cap has decreased by -46.50% in one year.

Market Cap

116.03M

Enterprise Value

172.57M

1-Year Change

-46.50%

Ranking

#4096

Market Cap Chart

Since October 13, 2017, OptiNose's market cap has decreased from $672.30M to $116.03M, a decrease of -82.74%. That is a compound annual growth rate of -23.62%.

Market Cap History

Date	Market Cap	% Change
Apr 19, 2024	100.70M	-3.64%
Apr 18, 2024	104.50M	-9.05%
Apr 17, 2024	114.90M	-6.43%
Apr 16, 2024	122.80M	-8.43%
Apr 15, 2024	134.10M	-2.40%
Apr 12, 2024	137.40M	-1.65%
Apr 11, 2024	139.70M	-0.78%
Apr 10, 2024	140.80M	1.59%
Apr 9, 2024	138.60M	-7.48%
Apr 8, 2024	149.80M	0.74%
Apr 5, 2024	148.70M	-3.63%
Apr 4, 2024	154.30M	-0.77%
Apr 3, 2024	155.50M	-2.08%
Apr 2, 2024	158.80M	-2.10%
Apr 1, 2024	162.20M	-1.40%
Mar 28, 2024	164.50M	-1.32%
Mar 27, 2024	166.70M	-
Mar 26, 2024	166.70M	-1.36%
Mar 25, 2024	169.00M	-7.95%
Mar 22, 2024	183.60M	-1.82%
Mar 21, 2024	187.00M	-3.21%
Mar 20, 2024	193.20M	-0.31%
Mar 19, 2024	193.80M	-11.10%
Mar 18, 2024	218.00M	2.93%
Mar 15, 2024	211.80M	-1.03%

View and export this data all the way back to 2017. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
TruBridge	119.54M
Outset Medical	118.18M
Citius Pharmaceuticals	116.81M
Relmada Therapeutics	116.77M
Coya Therapeutics	116.20M
GlycoMimetics	116.01M
InterCure	115.30M
Cardiol Therapeutics	114.60M

Market Cap Rankings